- Home
- TMO vs ABT Comparison
TMO vs ABT Comparison
Compare TMO & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMO
- ABT
- Stock Information
- Founded
- TMO 1956
- ABT 1888
- Country
- TMO United States
- ABT United States
- Employees
- TMO N/A
- ABT N/A
- Industry
- TMO Industrial Machinery/Components
- ABT Medical/Dental Instruments
- Sector
- TMO Industrials
- ABT Health Care
- Exchange
- TMO Nasdaq
- ABT Nasdaq
- Market Cap
- TMO 201.9B
- ABT 231.5B
- IPO Year
- TMO N/A
- ABT N/A
- Fundamental
- Price
- TMO $538.37
- ABT $128.66
- Analyst Decision
- TMO Buy
- ABT Strong Buy
- Analyst Count
- TMO 16
- ABT 18
- Target Price
- TMO $589.13
- ABT $146.61
- AVG Volume (30 Days)
- TMO 2.5M
- ABT 6.4M
- Earning Date
- TMO 10-22-2025
- ABT 10-15-2025
- Dividend Yield
- TMO 0.32%
- ABT 1.84%
- EPS Growth
- TMO 7.24
- ABT 141.96
- EPS
- TMO 17.30
- ABT 7.96
- Revenue
- TMO $43,212,000,000.00
- ABT $43,843,000,000.00
- Revenue This Year
- TMO $3.54
- ABT $7.61
- Revenue Next Year
- TMO $4.83
- ABT $7.84
- P/E Ratio
- TMO $31.16
- ABT $16.15
- Revenue Growth
- TMO 2.04
- ABT 6.37
- 52 Week Low
- TMO $385.46
- ABT $110.86
- 52 Week High
- TMO $610.97
- ABT $141.23
- Technical
- Relative Strength Index (RSI)
- TMO 66.11
- ABT 39.78
- Support Level
- TMO $519.45
- ABT $125.74
- Resistance Level
- TMO $544.60
- ABT $133.34
- Average True Range (ATR)
- TMO 15.35
- ABT 2.95
- MACD
- TMO 0.81
- ABT -0.71
- Stochastic Oscillator
- TMO 87.62
- ABT 30.07
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.